MedPath

An open-label study to determine the usefulness of the dried blood spot method for phenotyping and genotyping of CYP450 enzymes and the determination of trace elements in healthy volunteers.

Completed
Conditions
iet van toepassing
Not applicable
Registration Number
NL-OMON35088
Lead Sponsor
Xendo Drug Development
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
12
Inclusion Criteria

Healthy male and female
Age between 18-45 years

Exclusion Criteria

Clinical significant abnormalities at medical research

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>To compare the results of analysis of midazolam between the dried blood spot<br /><br>method and plasma as well as whole blood, all drawn by venipuncture.</p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath